Delivery Order SPE2DB20D3103-SPE2DB23FM0E1
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,598,248 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $22,819.19 and runs through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,061.84, is for the delivery of 4,567,475,840 units of Naloxone HCL 4 mg nasal spray, a critical medication used in the treatment of opioid overdoses. The contract is a firm-fixed-price delivery order with a period of performance through March 6, 2025. This award is part of a larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,549,272 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a total ceiling value of $3,275.59 and a completion date of October 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,008,836 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,171.34 and a period of performance through April 24, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,486,292 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $20,243.49 and a completion date of March 7, 2025. This award is associated with a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a firm fixed price of $1,342.48 and a period of performance through March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,908,804 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,437.31 and a completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation,...
- This federal contract award, valued at $1,039.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,830,894 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price, with a completion date of May 5, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The delivery order is valued at $2,188.87 and has a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM0E1Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/28/22 |